MLH1 and cancer: Longitudinal case‐by‐case analyses suggested sequential trajectories in, for example, LOC22, in which a somatic second hit of MLH1 and somatic variants in several cancer‐associated genes were shared between the endpoint carcinomas and atypical hyperplasia samples from the time of 9 and 7 years before (Figure 2B).